ytterbium has been researched along with Lymphoma, B-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axworthy, D; Hedin, N; Lin, Y; Pagel, JM; Pantelias, A; Press, OW | 1 |
1 other study(ies) available for ytterbium and Lymphoma, B-Cell
Article | Year |
---|---|
A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies.
Topics: Amino Acid Sequence; Animals; Base Sequence; Biotin; Cell Line, Tumor; Female; Humans; Immunoglobulin Fragments; Leukocyte Common Antigens; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Organometallic Compounds; Protein Engineering; Radioimmunotherapy; Radioisotopes; Recombinant Fusion Proteins; Streptavidin; Ytterbium | 2006 |